Labeler · US market
Lilly del Caribe, Inc.
Lilly del Caribe, Inc. is a US drug labeler with US FDA registrations covering 12 drug concepts (10 currently active) across 48 packages. It is currently the only active US supplier of 5 drugs.
ACTIVE — US
openFDA · updated weekly
Labeler codes0110
Active drugs10
Registrations36 active / 46
Packages48
Sole supplier of5 drugs
Portfolio12 drugs · US
Every drug concept this labeler has US registrations for, by package count.
| Drug | Type | NDCs | Packages | Status |
|---|---|---|---|---|
| Duloxetine Hydrochloride capsule, delayed release | other | 7 | 7 | SUPPLYING |
| Orforglipron capsule | other | 6 | 6 | SUPPLYING |
| Orforglipron tablet, film coated | other | 6 | 6 | SUPPLYING |
| Tadalafil tablet, film coated | other | 4 | 4 | SUPPLYING |
| Insulin Lispro crystal | other | 2 | 4 | SUPPLYING |
| Abemaciclib tablet | other | 4 | 4 | SUPPLYING |
| Baricitinib tablet, film coated | other | 3 | 3 | SUPPLYING |
| Lasmiditan tablet | other | 2 | 2 | SUPPLYING |
| Tadalafil tablet | other | 1 | 1 | SUPPLYING |
| Raloxifene Hydrochloride tablet | other | 1 | 1 | SUPPLYING |
| Atomoxetine Hydrochloride capsule | other | 7 | 7 | DISCONTINUED |
| Fluoxetine Hydrochloride capsule | other | 3 | 3 | DISCONTINUED |
Pill